New England Journal of Medicine· 2014Q1

AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

Emmanuel S. Antonarakis, Changxue Lu, Hao Wang, Brandon Luber et al.

2,705citations
Q1SCImago
2014year

Short summary

Detecting AR-V7 mRNA in circulating tumor cells (CTCs) from men with metastatic castration-resistant prostate cancer (mCRPC) is associated with resistance to enzalutamide and abiraterone.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Pulmonary and Respiratory Medicine

Pulmonary and Respiratory MedicineMedicine